When Jessica Turner was diagnosed with multiple sclerosis (MS) at age 31, she didn’t want to talk about it—and she didn’t want to take drugs.
“I wasn’t ready to accept that this was happening to me,” Turner tells The GrowthOp. She also didn’t want to accept experiencing the flu-like symptoms that so often accompany interferons, the oldest and most prescribed drug options for patients with relapsing-remitting MS.
Now, 11 years later, Turner has come to terms with her disease and is happy to share her story (she even has a blog) but she still isn’t interested in popping pills to manage her symptoms or prevent a relapse. “I don’t feel sick and I don’t want to feel sick,” she says.
MS Society of Canada announced in March that it will provide $1.5 million to the Canadian Institutes of Health Research (CIHR) to fund cannabis and MS research over the next five…